Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer

Cooper, David S., Doherty, Gerard M., Haugen, Bryan R., Kloos, Richard T., Lee, Stephanie L., Mandel, Susan J., Mazzaferri, Ernest L., McIver, Bryan +5 more·2009·Thyroid

Cited by (1,021)

Items 1,001–1,021 of 1,021

  1. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study
    Fallahi, Poupak, Ferrari, Silvia Martina, Antonelli, Alessandro · 2016 · Endocrine
  2. Targeted Radionuclide Therapy: Practical Applications and Future Prospects: Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies (A)
    Zukotynski, Katherine, Jadvar, Hossein, Capala, Jacek, Fahey, Frederic · 2016 · Biomarkers in Cancer
  3. Effect of patient Age on surgical outcomes for Graves’ disease: a case–control study of 100 consecutive patients at a high volume thyroid surgical center
    Breuer, Christopher K, Solomon, Daniel, Donovan, Patricia, Rivkees, Scott A, Udelsman, Robert · 2013 · International Journal of Pediatric Endocrinology
  4. Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study
    VAN ZAANE, B., SQUIZZATO, A., DEBEIJ, J., DEKKERS, O.M., MEIJERS, J.C.M., VAN ZANTEN, A.P., BÜLLER, H.R., GERDES, V.E.A., CANNEGIETER, S.C., BRANDJES, D.P.M. · 2011 · Journal of Thrombosis and Haemostasis
  5. Calcitonin as a biomarker of C cell disease: recent achievements and current challenges
    Costante, Giuseppe, Meringolo, Domenico · 2020 · Endocrine
  6. Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Bethel, M. Angelyn, Patel, Rishi A., Thompson, Vivian P., Merrill, Peter, Reed, Shelby D., Li, Yanhong, Ahmadi, Sara, Katona, Brian G., Gustavson, Stephanie M., Ohman, Peter et al. · 2019 · Diabetes Care
  7. Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance
    Jung, Min Jung, Kwon, Su Kyoung · 2014 · Endocrinology and Metabolism
  8. Preoperative contrast-enhanced computerized tomography should not delay radioiodine ablation in differentiated thyroid carcinoma patients
    Mishra, Anjali, Pradhan, Prasanta Kumar, Gambhir, Sanjay, Sabaretnam, Myilvaganan, Gupta, Archana, Babu, Satish · 2015 · Journal of Surgical Research
  9. Levothyroxine dose following thyroidectomy is affected by more than just body weight
    Baehr, Kara Meinke, Lyden, Elizabeth, Treude, Kelly, Erickson, Judi, Goldner, Whitney · 2012 · The Laryngoscope
  10. Pharmacokinetics of L-Triiodothyronine in Patients Undergoing Thyroid Hormone Therapy Withdrawal
    Van Tassell, Benjamin, Wohlford, George F., Linderman, Joyce D., Smith, Sheila, Yavuz, Sahzene, Pucino, Frank, Celi, Francesco S. · 2019 · Thyroid®
  11. J-Shaped Association Between Postoperative Levothyroxine Dosage and Fracture Risk in Thyroid Cancer Patients: A Retrospective Cohort Study
    Shin, Dong Wook, Suh, Beomseok, Lim, Hyunsun, Yun, Jae Moon, Song, Sun Ok, Park, Youngmin · 2018 · Journal of Bone and Mineral Research
  12. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer
    Michelotti, Gregory, Jiang, Xiaoyin, Sosa, Julie Ann, Diehl, Anna Mae, Henderson, Brittany Bohinc · 2015 · Oncotarget
  13. Risk of Secondary Solid Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation and Preventive Strategies
    Adhikari, Janak, Sharma, Priyadarshani, Bhatt, Vijaya Raj · 2015 · Future Oncology
  14. Individually-tailored thyroxine requirement in the same patients before and after thyroidectomy: a longitudinal study
    Del Duca, S C, Santaguida, M G, Brusca, N, Gatto, I, Cellini, M, Gargano, L, Verga Falzacappa, C, Frattaroli, F M, Virili, C, Centanni, M · 2015 · European Journal of Endocrinology
  15. Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells
    Chen, Haibo, Luo, Dingyuan, Zhang, Lin, Lin, Xiaofeng, Luo, Qiuyun, Yi, Hanjie, Wang, Jing, Yan, Xianglei, Li, Baoxia, Chen, Yuelei et al. · 2017 · Oncotarget
  16. An Exploratory Study of Fatigue and Physical Activity in Canadian Thyroid Cancer Patients
    Alhashemi, Ahmad, Jones, Jennifer M., Goldstein, David P., Mina, Daniel Santa, Thabane, Lehana, Sabiston, Catherine M., Chang, Eugene K., Brierley, James D., Sawka, Anna M. · 2017 · Thyroid
  17. Simulation of post-thyroidectomy treatment alternatives for triiodothyronine or thyroxine replacement in pediatric thyroid cancer patients
    Ben-Shachar, Rotem, Eisenberg, Marisa, Huang, Stephen A., DiStefano, Joseph J. · 2012 · Thyroid
  18. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy
    Verburg, Frederik A., Smit, Johannes W. A., Grelle, Inge, Visser, Theo J., Peeters, Robin P., Reiners, Christoph · 2012 · Clinical Endocrinology
  19. Rethinking the role of oncogenes in papillary thyroid cancer initiation
    Vitale, Mario · 2012 · Frontiers in Endocrinology
  20. ENTAgents: AI Agents for Complex Knowledge Otolaryngology
    Chan, Tsz Kin, Dinh, Ngoc-Duy · 2025
  21. Genetic mutations, molecular markers and future directions in research
    Patel, Kepal N. · 2013 · Oral Oncology